Supporting oncology professionals through education

The content on this site is intended for healthcare professionals only

News [8503]

TGIF2-mediated HMGB3 overexpression drives oesophageal squamous cell carcinoma (ESCC)

TGIF2-mediated HMGB3 overexpression drives oesophageal squamous cell carcinoma (ESCC)

Vitamin D analog shuts down pancreatic cancer’s shield in clinical trial

Vitamin D analog shuts down pancreatic cancer’s shield in clinical trial

Sacituzumab govitecan receives positive CHMP opinion in first-line metastatic triple-negative Breast cancer

Sacituzumab govitecan receives positive CHMP opinion in first-line metastatic triple-negative Breast cancer

Researchers identify new indicator for response to therapy in pediatric cancers

Researchers identify new indicator for response to therapy in pediatric cancers

Cholesterol-craving cancers need lipid enzymes to use metabolites for growth

Cholesterol-craving cancers need lipid enzymes to use metabolites for growth

ASCO 2026: Less cognitive decline with darolutamide treatment than enzalutamide in people with advanced prostate cancer

ASCO 2026: Less cognitive decline with darolutamide treatment than enzalutamide in people with advanced prostate...

ASCO 2026: Trial tests virus-immunotherapy combination for neuroendocrine tumours

ASCO 2026: Trial tests virus-immunotherapy combination for neuroendocrine tumours

ASCO 2026: Genetic clues may reveal which rare solitary fibrous tumours are more aggressive, likely to spread

ASCO 2026: Genetic clues may reveal which rare solitary fibrous tumours are more aggressive, likely to spread

Study identifies new marker to find patients with advanced prostate cancer more likely to benefit from combination immunotherapy

Study identifies new marker to find patients with advanced prostate cancer more likely to benefit from combination...

A new approach to cancer vaccination yields more powerful t cells

A new approach to cancer vaccination yields more powerful t cells

More from ecancer